AdAlta Banner Image


  • Ticker 1AD
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
AdAlta Logo Image
  • 1-10 Employees
  • Based in Melbourne, Australia
AdAlta is the pioneer of a novel technology platform that mimics the shape and engineers key stability features of the antigen binding domain of shark antibodies into human proteins to create unique compounds, known as i-bodies, for therapeutic intervention in disease.

Most Recent Annual Report

MOST RECENT 2021 Annual Report

Older/Archived Annual Reports